$FFNTF
4Front Ventures Corp. Stock $ffntf

$ffntf Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000119312522221330 Filed on August 15, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$32.47M	$28.44M	$26.05M
YoY Change	25.18%	4.86%	13.4%
Cost Of Revenue	$17.43M	$16.12M	$12.59M
YoY Change	69.7%	49.07%	38.02%
Gross Profit	$15.05M	$12.32M	$13.45M
YoY Change	-3.99%	-24.46%	-2.82%
Gross Profit Margin	46.34%	43.31%	51.65%
Selling, General & Admin	$12.59M	$12.89M	$13.85M
YoY Change	-20.15%	9.29%	34.16%
% of Gross Profit	83.66%	104.68%	102.93%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.400M	$2.217M	$1.795M
YoY Change	-6.79%	228.44%	71.61%
% of Gross Profit	9.3%	18.0%	13.34%
Operating Expenses	$14.53M	$16.42M	$14.70M
YoY Change	-12.45%	4.98%	8.92%
Operating Profit	$517.0K	-$4.099M	-$1.241M
YoY Change	-155.95%	-713.62%	-451.56%
Interest Expense	$4.157M	$3.418M	-$1.318M
YoY Change	410.06%	17.82%	-153.56%
% of Operating Profit	804.06%
Other Income/Expense, Net	-$1.815M	-$154.0K	$103.0K
YoY Change	-3341.07%		-103.53%
Pretax Income	-$5.279M	-$3.504M	-$2.456M
YoY Change	9860.38%	22.22%	-70.87%
Income Tax	$3.322M	$3.042M	$3.438M
% Of Pretax Income
Net Earnings	-$8.606M	-$6.551M	-$5.894M
YoY Change	87.13%	5.27%	-46.85%
Net Earnings / Revenue	-26.5%	-23.04%	-22.63%
Basic Earnings Per Share	-$0.01	$0.01	-$0.01
Diluted Earnings Per Share	-$0.01	$0.01	-$9.528K
COMMON SHARES
Basic Shares Outstanding	636.6M	636.7M	619.1M shares
Diluted Shares Outstanding	639.6M shares	636.7M	619.1M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.286M	$6.032M	$8.638M
YoY Change	-37.64%	-47.83%	-51.49%
Cash & Equivalents	$5.286M	$6.032M	$8.638M
Short-Term Investments
Other Short-Term Assets	$2.392M	$2.974M	$2.079M
YoY Change	-0.08%	33.66%	-33.04%
Inventory	$30.94M	$28.84M	$25.91M
Prepaid Expenses		$2.974M
Receivables	$8.722M	$5.844M	$2.742M
Other Receivables	$20.00K	$33.00K	$4.440M
Total Short-Term Assets	$51.12M	$47.13M	$43.81M
YoY Change	18.15%	13.11%	-1.01%
LONG-TERM ASSETS
Property, Plant & Equipment	$58.70M	$58.97M	$157.2M
YoY Change	-45.48%	-43.83%	297.58%
Goodwill	$41.39M	$42.04M
YoY Change	78.76%	81.55%
Intangibles	$54.45M	$54.24M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$5.165M	$5.142M	$5.107M
YoY Change	23.86%	19.72%	9.01%
Total Long-Term Assets	$268.9M	$273.3M	$246.9M
YoY Change	59.25%	63.57%	49.93%
TOTAL ASSETS
Total Short-Term Assets	$51.12M	$47.13M	$43.81M
Total Long-Term Assets	$268.9M	$273.3M	$246.9M
Total Assets	$320.0M	$320.5M	$290.7M
YoY Change	50.86%	53.5%	39.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$11.30M	$6.391M	$5.110M
YoY Change	139.67%	16.54%	-22.29%
Accrued Expenses	$15.05M	$17.15M	$11.30M
YoY Change	55.09%	156.15%	12.87%
Deferred Revenue	$700.0K	$1.535M
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$9.299M	$8.235M	$5.385M
YoY Change	36.41%	25.94%	-10.43%
Total Short-Term Liabilities	$69.12M	$63.39M	$51.61M
YoY Change	38.33%	38.04%	16.66%
LONG-TERM LIABILITIES
Long-Term Debt	$75.21M	$74.70M	$65.28M
YoY Change	52.26%	53.51%	10.63%
Other Long-Term Liabilities	$119.5M	$120.6M	$113.1M
YoY Change	121.31%	125.6%	101.44%
Total Long-Term Liabilities	$75.21M	$74.70M	$178.4M
YoY Change	52.26%	53.51%	202.29%
TOTAL LIABILITIES
Total Short-Term Liabilities	$69.12M	$63.39M	$51.61M
Total Long-Term Liabilities	$75.21M	$74.70M	$178.4M
Total Liabilities	$270.7M	$265.6M	$237.2M
YoY Change	68.58%	71.11%	42.43%
SHAREHOLDERS EQUITY
Retained Earnings	-$309.9M	-$301.3M
YoY Change		12.49%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$49.18M	$54.82M	$53.46M
YoY Change
Total Liabilities & Shareholders Equity	$320.0M	$320.5M	$290.7M
YoY Change	50.86%	53.5%	39.14%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$8.606M	-$6.551M	-$5.894M
YoY Change	87.13%	5.27%	-46.85%
Depreciation, Depletion And Amortization	$1.400M	$2.217M	$1.795M
YoY Change	-6.79%	228.44%	71.61%
Cash From Operating Activities	$905.0K	-$516.0K	-$2.368M
YoY Change	-402.68%	-135.51%	-184.15%
INVESTING ACTIVITIES
Capital Expenditures	-$286.0K	-$1.140M	-$1.109M
YoY Change	-84.0%	-77.42%	-115.43%
Acquisitions			$25.00M
YoY Change
Other Investing Activities	-$7.000K	$469.0K	-$24.90M
YoY Change	-96.85%	37.13%	-2253.98%
Cash From Investing Activities	-$293.0K	-$671.0K	-$26.01M
YoY Change	-85.42%	-85.74%	331.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.358M	-1.419M	14.43M
YoY Change	74.55%	-52.54%	590.62%
NET CHANGE
Cash From Operating Activities	905.0K	-516.0K	-2.368M
Cash From Investing Activities	-293.0K	-671.0K	-26.01M
Cash From Financing Activities	-1.358M	-1.419M	14.43M
Net Change In Cash	-746.0K	-2.606M	-13.94M
YoY Change	-75.83%	-58.26%	1138.28%
FREE CASH FLOW
Cash From Operating Activities	$905.0K	-$516.0K	-$2.368M
Capital Expenditures	-$286.0K	-$1.140M	-$1.109M
Free Cash Flow	$1.191M	$624.0K	-$1.259M
YoY Change	-19.96%	-90.4%	-71.2%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
	us-gaap	Net Income Loss NetIncomeLoss	-12450000
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Central Index Key EntityCentralIndexKey	0001783875
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-56075
	dei	Entity Registrant Name EntityRegistrantName	4Front Ventures Corp.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	A1
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	83-4168417
	dei	Entity Address Address Line1 EntityAddressAddressLine1	5060 N. 40th Street
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 120
	dei	Entity Address City Or Town EntityAddressCityOrTown	Phoenix
	dei	Entity Address State Or Province EntityAddressStateOrProvince	AZ
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	85018
	dei	City Area Code CityAreaCode	602
	dei	Local Phone Number LocalPhoneNumber	633-3067
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	636636686
CY2022Q2	us-gaap	Cash Cash	6032000
CY2021Q4	us-gaap	Cash Cash	22581000
CY2021Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	109000
CY2022Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2974000
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5844000
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1946000
CY2022Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	33000
CY2021Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	289000
CY2022Q2	us-gaap	Lease Incentive Receivable Current LeaseIncentiveReceivableCurrent	3405000
CY2021Q4	us-gaap	Lease Incentive Receivable Current LeaseIncentiveReceivableCurrent	3630000
CY2022Q2	us-gaap	Inventory Net InventoryNet	28837000
CY2021Q4	us-gaap	Inventory Net InventoryNet	20087000
CY2022Q2	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	0
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2232000
CY2022Q2	us-gaap	Assets Current AssetsCurrent	47125000
CY2021Q4	us-gaap	Assets Current AssetsCurrent	50874000
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	58967000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	42633000
CY2022Q2	us-gaap	Lease Incentive Receivable Noncurrent LeaseIncentiveReceivableNoncurrent	6541000
CY2021Q4	us-gaap	Lease Incentive Receivable Noncurrent LeaseIncentiveReceivableNoncurrent	6748000
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	54239000
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	26246000
CY2022Q2	us-gaap	Goodwill Goodwill	42037000
CY2021Q4	us-gaap	Goodwill Goodwill	23155000
CY2022Q2	ffntf	Right Of Use Assets RightOfUseAssets	106406000
CY2021Q4	ffntf	Right Of Use Assets RightOfUseAssets	100519000
CY2022Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	5142000
CY2021Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	5364000
CY2022Q2	us-gaap	Assets Assets	320457000
CY2021Q4	us-gaap	Assets Assets	255539000
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	6391000
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2131000
CY2022Q2	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	13031000
CY2021Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	9411000
CY2022Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	29651000
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	23968000
CY2022Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	428000
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	3502000
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1535000
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	0
CY2022Q2	ffntf	Convertible Notes Current ConvertibleNotesCurrent	0
CY2021Q4	ffntf	Convertible Notes Current ConvertibleNotesCurrent	2784000
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4121000
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3629000
CY2022Q2	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	8235000
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	3413000
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	63392000
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	48838000
CY2022Q2	ffntf	Convertible Notes Noncurrent ConvertibleNotesNoncurrent	15205000
CY2021Q4	ffntf	Convertible Notes Noncurrent ConvertibleNotesNoncurrent	14641000
CY2022Q2	ffntf	Notes Payable And Accrued Interest From Related Party NotesPayableAndAccruedInterestFromRelatedParty	49366000
CY2021Q4	ffntf	Notes Payable And Accrued Interest From Related Party NotesPayableAndAccruedInterestFromRelatedParty	48266000
CY2022Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	10128000
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	1709000
CY2022Q2	ffntf	Accounts Payable Noncurrent AccountsPayableNoncurrent	1200000
CY2021Q4	ffntf	Accounts Payable Noncurrent AccountsPayableNoncurrent	1200000
CY2022Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	2000000
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	0
CY2022Q2	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	0
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	2393000
CY2022Q2	us-gaap	Construction Loan Noncurrent ConstructionLoanNoncurrent	16000000
CY2021Q4	us-gaap	Construction Loan Noncurrent ConstructionLoanNoncurrent	0
CY2022Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	6884000
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	7849000
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	101380000
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	93111000
CY2022Q2	us-gaap	Liabilities Liabilities	265555000
CY2021Q4	us-gaap	Liabilities Liabilities	218007000
CY2022Q2	ffntf	Equity Attributable EquityAttributable	302502000
CY2021Q4	ffntf	Equity Attributable EquityAttributable	274120000
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	53625000
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	52197000
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-301307000
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-288857000
CY2022Q2	us-gaap	Minority Interest MinorityInterest	82000
CY2021Q4	us-gaap	Minority Interest MinorityInterest	72000
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	54902000
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	37532000
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	320457000
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	255539000
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	25488000
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	24452000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	48571000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	44532000
CY2022Q2	us-gaap	Profit Loss From Real Estate Operations ProfitLossFromRealEstateOperations	2951000
CY2021Q2	us-gaap	Profit Loss From Real Estate Operations ProfitLossFromRealEstateOperations	2669000
	us-gaap	Profit Loss From Real Estate Operations ProfitLossFromRealEstateOperations	5916000
	us-gaap	Profit Loss From Real Estate Operations ProfitLossFromRealEstateOperations	5559000
CY2022Q2	us-gaap	Revenues Revenues	28439000
CY2021Q2	us-gaap	Revenues Revenues	27121000
	us-gaap	Revenues Revenues	54487000
	us-gaap	Revenues Revenues	50091000
CY2022Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	16123000
CY2021Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	10816000
CY2021Q2	ffntf	Gains Losses On Change In Fair Value Of Derivatives GainsLossesOnChangeInFairValueOfDerivatives	-311000
	ffntf	Gains Losses On Change In Fair Value Of Derivatives GainsLossesOnChangeInFairValueOfDerivatives	3074000
	ffntf	Gains Losses On Change In Fair Value Of Derivatives GainsLossesOnChangeInFairValueOfDerivatives	-2843000
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	28717000
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	19941000
CY2022Q2	us-gaap	Gross Profit GrossProfit	12316000
CY2021Q2	us-gaap	Gross Profit GrossProfit	16305000
	us-gaap	Gross Profit GrossProfit	25770000
	us-gaap	Gross Profit GrossProfit	30150000
CY2022Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	6327000
CY2021Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	6714000
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	11493000
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	11871000
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6566000
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5083000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14210000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10248000
CY2022Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1123000
CY2021Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	861000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1970000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1635000
CY2022Q2	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	2009000
CY2021Q2	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	0
	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	2009000
	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	0
CY2022Q2	us-gaap	Share Based Compensation ShareBasedCompensation	390000
CY2021Q2	us-gaap	Share Based Compensation ShareBasedCompensation	2979000
	us-gaap	Share Based Compensation ShareBasedCompensation	1428000
	us-gaap	Share Based Compensation ShareBasedCompensation	5375000
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	16415000
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	15637000
	us-gaap	Operating Expenses OperatingExpenses	31110000
	us-gaap	Operating Expenses OperatingExpenses	29129000
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-4099000
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	668000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-5340000
	us-gaap	Operating Income Loss OperatingIncomeLoss	1021000
CY2022Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	0
CY2021Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	8000
	us-gaap	Investment Income Interest InvestmentIncomeInterest	2000
	us-gaap	Investment Income Interest InvestmentIncomeInterest	11000
CY2022Q2	us-gaap	Interest Expense InterestExpense	3418000
CY2021Q2	us-gaap	Interest Expense InterestExpense	2901000
	us-gaap	Interest Expense InterestExpense	6038000
	us-gaap	Interest Expense InterestExpense	5362000
CY2022Q2	ffntf	Amortization Of Loan Discount Upon Conversion Of Debt To Equity AmortizationOfLoanDiscountUponConversionOfDebtToEquity	0
CY2021Q2	ffntf	Amortization Of Loan Discount Upon Conversion Of Debt To Equity AmortizationOfLoanDiscountUponConversionOfDebtToEquity	0
	ffntf	Amortization Of Loan Discount Upon Conversion Of Debt To Equity AmortizationOfLoanDiscountUponConversionOfDebtToEquity	0
	ffntf	Amortization Of Loan Discount Upon Conversion Of Debt To Equity AmortizationOfLoanDiscountUponConversionOfDebtToEquity	2915000
CY2022Q2	ffntf	Gains Losses On Change In Fair Value Of Derivatives GainsLossesOnChangeInFairValueOfDerivatives	1774000
CY2022Q2	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-2393000
CY2021Q2	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-2393000
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0
CY2022Q2	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	0
CY2021Q2	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	-331000
	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	0
	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	-1210000
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-154000
CY2021Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-51000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0
CY2022Q2	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	595000
CY2021Q2	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-3535000
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-620000
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-12319000
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3504000
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2867000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5960000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11298000
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3042000
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3351000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6480000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6004000
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-6546000
CY2021Q2	us-gaap	Profit Loss ProfitLoss	-6218000
	us-gaap	Profit Loss ProfitLoss	-12440000
	us-gaap	Profit Loss ProfitLoss	-17302000
CY2022Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	5000
CY2021Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	5000
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	10000
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	10000
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-6551000
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-6223000
	us-gaap	Net Income Loss NetIncomeLoss	-12450000
	us-gaap	Net Income Loss NetIncomeLoss	-17312000
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	636653975
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	636653975
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	587218794
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	587218794
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	628175765
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	628175765
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	573108183
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	573108183
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	37532000
CY2022Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	18200000
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1038000
CY2022Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	3122000
CY2022Q1	ffntf	Shares Issued With Exercise Of Warrants One SharesIssuedWithExerciseOfWarrantsOne	50000
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-5894000
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	54048000
CY2022Q2	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	6245000
CY2022Q2	ffntf	Warrants Issued During Period Value Acquisitions WarrantsIssuedDuringPeriodValueAcquisitions	732000
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	390000
CY2022Q2	ffntf	Stock Issued During Period Value Warrants And Stock Options Exercised StockIssuedDuringPeriodValueWarrantsAndStockOptionsExercised	33000
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-6546000
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	54902000
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	42203000
CY2021Q1	ffntf	Shares Issued During Period Value Earnout SharesIssuedDuringPeriodValueEarnout	161000
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2396000
CY2021Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	6253000
CY2021Q1	ffntf	Stock Issued During Period Value Warrants And Stock Options Exercised StockIssuedDuringPeriodValueWarrantsAndStockOptionsExercised	871000
CY2021Q1	ffntf	Shares Issued With Exercise Of Warrants One SharesIssuedWithExerciseOfWarrantsOne	1563000
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-11084000
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	42363000
CY2021Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2979000
CY2021Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	11466000
CY2021Q2	ffntf	Stock Issued During Period Value Warrants And Stock Options Exercised StockIssuedDuringPeriodValueWarrantsAndStockOptionsExercised	443000
CY2021Q2	ffntf	Shares Issued With Exercise Of Warrants One SharesIssuedWithExerciseOfWarrantsOne	1813000
CY2021Q2	us-gaap	Profit Loss ProfitLoss	-6218000
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	53568000
	us-gaap	Profit Loss ProfitLoss	-12440000
	us-gaap	Profit Loss ProfitLoss	-17302000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4689000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2166000
	us-gaap	Share Based Compensation ShareBasedCompensation	1428000
	us-gaap	Share Based Compensation ShareBasedCompensation	5375000
	ffntf	Gains Losses On Change In Fair Value Of Derivatives GainsLossesOnChangeInFairValueOfDerivatives	3074000
	ffntf	Gains Losses On Change In Fair Value Of Derivatives GainsLossesOnChangeInFairValueOfDerivatives	-2843000
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-2393000
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0
	ffntf	Amortization Of Right Of Use Assets AmortizationOfRightOfUseAssets	0
	ffntf	Amortization Of Right Of Use Assets AmortizationOfRightOfUseAssets	1765000
	ffntf	Accretion Of Lease Liability AccretionOfLeaseLiability	-2803000
	ffntf	Accretion Of Lease Liability AccretionOfLeaseLiability	478000
	ffntf	Write Off Of Fixed Asset From Terminated Lease WriteOffOfFixedAssetFromTerminatedLease	0
	ffntf	Write Off Of Fixed Asset From Terminated Lease WriteOffOfFixedAssetFromTerminatedLease	1210000
	ffntf	Accretion Of Contingent Consideration AccretionOfContingentConsideration	0
	ffntf	Accretion Of Contingent Consideration AccretionOfContingentConsideration	228000
	ffntf	Accretion Of Convertible Debentures And Interest AccretionOfConvertibleDebenturesAndInterest	564000
	ffntf	Accretion Of Convertible Debentures And Interest AccretionOfConvertibleDebenturesAndInterest	850000
	ffntf	Accrued Interest On Notes Payable AccruedInterestOnNotesPayable	3614000
	ffntf	Accrued Interest On Notes Payable AccruedInterestOnNotesPayable	3884000
	ffntf	Adjustment For Interest Accrued Lease Receivable AdjustmentForInterestAccruedLeaseReceivable	-432000
	ffntf	Adjustment For Interest Accrued Lease Receivable AdjustmentForInterestAccruedLeaseReceivable	-349000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-965000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	632000
	ffntf	Amortization Of Loan Discount AmortizationOfLoanDiscount	0
	ffntf	Amortization Of Loan Discount AmortizationOfLoanDiscount	2915000
	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	-2458000
	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	170000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2884000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4267000
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	24998000
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0
	ffntf	Cash Acquired From Acquisitions CashAcquiredFromAcquisitions	458000
	ffntf	Cash Acquired From Acquisitions CashAcquiredFromAcquisitions	0
	ffntf	Proceeds From Payments For Collection Of Notes Receivable ProceedsFromPaymentsForCollectionOfNotesReceivable	109000
	ffntf	Proceeds From Payments For Collection Of Notes Receivable ProceedsFromPaymentsForCollectionOfNotesReceivable	405000
	ffntf	Proceeds From Sale Of Dispensaries And Interest In Licenses ProceedsFromSaleOfDispensariesAndInterestInLicenses	0
	ffntf	Proceeds From Sale Of Dispensaries And Interest In Licenses ProceedsFromSaleOfDispensariesAndInterestInLicenses	1093000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2249000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	12234000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-26680000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10736000
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	412000
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	1204000
	us-gaap	Proceeds From Construction Loans Payable ProceedsFromConstructionLoansPayable	16000000
	us-gaap	Proceeds From Construction Loans Payable ProceedsFromConstructionLoansPayable	0
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	50000
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1664000
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	33000
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1314000
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	2656000
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	2674000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	13015000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-900000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-16549000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-7369000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	22581000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	18932000
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6032000
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	11563000
	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 1: NATURE OF OPERATIONS </div></div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">4Front Ventures Corp. (“4Front” or the “Company”) exists pursuant to the provisions of the British Columbia Corporations Act. On July 31, 2019, 4Front Holdings LLC (“Holdings”) completed a Reverse Takeover Transaction (“RTO”) with Cannex Capital Holdings Inc. (“Cannex”) whereby Holdings acquired Cannex and the shareholders of Holdings became the controlling shareholders of the Company. Following the RTO, the Company’s SVS are listed on the Canadian Securities Exchange (“CSE”) under the ticker “FFNT” and are quoted on the OTC (OTCQX: FFNTF). </div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company has two primary operating segments: THC Cannabis and CBD Wellness. With regard to its THC Cannabis segment, as of June 30, 2022, the Company operates six dispensaries in Massachusetts, Illinois, and Michigan, primarily under the “MISSION” brand name. As of June 30, 2022, the Company operates three </div><div style="display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">production facilities in Massachusetts, Illinois and California and produces the majority of products that are sold at its own Massachusetts and Illinois dispensaries. Also, as part of its THC Cannabis segment, the Company leases real estate and sells equipment, supplies, and intellectual property to cannabis producers in the state of Washington. </div></div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">While marijuana is legal under the laws of several U.S. states (with varying restrictions), the United States Federal Controlled Substances Act classifies all “marijuana” as a Schedule 1 drug, whether for medical or recreational use. Under U.S. federal law, a Schedule I drug or substance has a high potential for abuse, no accepted medical use in the United States, and a lack of safety for the use of the drug under medical supervision. </div></div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The Company’s CBD Wellness segment is focused upon its ownership and operation of its wholly owned subsidiary, Pure Ratios Holdings, Inc. (“Pure Ratios”), a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">CBD-focused</div> wellness company in California, that sells <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-THC</div> hemp derived products throughout the United States. </div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On January 28, 2022, the Company entered into an agreement and plan of merger (the “NECC Merger Agreement”) with New England Cannabis Corporation, Inc., a Massachusetts Corporation (“NECC”) and a wholly owned subsidiary of the Company entered into an amended membership interest purchase agreement (the “Everett Purchase Agreement,” and together with the NECC Merger Agreement, the “NECC Merger Agreements”) with Kenneth Stevens to purchase all of the membership interests of 29 Everett, LLC (“29 Everett”), a Massachusetts limited liability company. See Note 7 for further details on the NECC Merger Agreements and corresponding transactions under such agreements. </div></div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On March 30, 2022, the Company entered into an agreement and plan of merger (the “Island Merger Agreement”) by and among the Company, Island Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“Island Merger Sub”); Island Global Holdings, Inc., a California corporation (“Island”); and Navy Capital SR LLC, a Delaware limited liability company (“Navy”, and together with the Company, Island Merger Sub, and Island, the “Island Parties”). In April 2022, pursuant to the terms and conditions of the Merger Agreement, Island Merger Sub merged with and into Island, with Island surviving the merger and continuing its corporate existence as a wholly owned subsidiary of the Company (the “Island Merger”). See Note 7 for further details on the Island Merger Agreements and corresponding transactions under such agreements. </div></div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Management continues to evaluate the impact of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic on the Company’s industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position and results of its operations, the specific impact is not readily determinable as of the date of these consolidated financial statements. The condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. </div></div> <div style="text-align: justify; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The corporate office address of the Company is 5060 North 40th Street, Suite 120, Phoenix, Arizona, and the Company’s registered office is 550 Burrard Street, Suite 2900, Vancouver, British Columbia. </div></div></div> <div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div>
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2
	ffntf	Number Of Dispensaries NumberOfDispensaries	6
CY2022Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	3535000
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1535000
CY2022Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	2000000
CY2022Q2	us-gaap	Other Inventory OtherInventory	2986000
CY2021Q4	us-gaap	Other Inventory OtherInventory	1734000
CY2022Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	7353000
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	8373000
CY2022Q2	us-gaap	Inventory Net InventoryNet	28837000
CY2021Q4	us-gaap	Inventory Net InventoryNet	20087000
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	70225000
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	50509000
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11258000
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7876000
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	58967000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	42633000
CY2022Q2	ffntf	Property Plant And Equipment Secured As Collateral PropertyPlantAndEquipmentSecuredAsCollateral	33000000
CY2022Q2	ffntf	Property Plant And Equipment Contractual Commitments PropertyPlantAndEquipmentContractualCommitments	0
CY2021Q4	ffntf	Property Plant And Equipment Contractual Commitments PropertyPlantAndEquipmentContractualCommitments	0
	us-gaap	Depreciation Depreciation	3382000
	us-gaap	Depreciation Depreciation	1138000
CY2022Q2	us-gaap	Depreciation Depreciation	2217000
CY2021Q2	us-gaap	Depreciation Depreciation	675000
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	28790000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2544000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	26246000
	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	18000000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1307000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	54239000
CY2020Q4	us-gaap	Goodwill Goodwill	23155000
CY2021Q4	us-gaap	Goodwill Goodwill	23155000
CY2022Q2	us-gaap	Goodwill Goodwill	42037000
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2022Q2	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	13400000
CY2021Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	13400000
CY2022Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	2595000
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	17719000
CY2021	us-gaap	Interest Expense Debt InterestExpenseDebt	11961000
CY2021Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	2400000
	us-gaap	Operating Lease Expense OperatingLeaseExpense	7417000
	us-gaap	Operating Lease Expense OperatingLeaseExpense	4868000
CY2022Q2	ffntf	Operating Lease Assets OperatingLeaseAssets	106406000
CY2021Q4	ffntf	Operating Lease Assets OperatingLeaseAssets	100519000
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4121000
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3629000
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	101380000
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	93111000
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	105501000
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	96740000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	8329000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	16987000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	17491000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	17633000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	18056000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	18076000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	234359000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	330931000
CY2022Q2	ffntf	Less Discounting LessDiscounting	225430000
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	105501000
CY2022Q2	us-gaap	Lease Incentive Receivable Noncurrent LeaseIncentiveReceivableNoncurrent	6541000
CY2022Q2	us-gaap	Lease Incentive Receivable Current LeaseIncentiveReceivableCurrent	3405000
CY2021Q4	us-gaap	Lease Incentive Receivable Noncurrent LeaseIncentiveReceivableNoncurrent	6748000
CY2021Q4	us-gaap	Lease Incentive Receivable Current LeaseIncentiveReceivableCurrent	3630000
CY2022Q2	us-gaap	Profit Loss From Real Estate Operations ProfitLossFromRealEstateOperations	2951000
CY2021Q2	us-gaap	Profit Loss From Real Estate Operations ProfitLossFromRealEstateOperations	2669000
	us-gaap	Profit Loss From Real Estate Operations ProfitLossFromRealEstateOperations	5916000
	us-gaap	Profit Loss From Real Estate Operations ProfitLossFromRealEstateOperations	5559000
CY2022Q2	us-gaap	Profit Loss From Real Estate Operations ProfitLossFromRealEstateOperations	2951000
CY2021Q2	us-gaap	Profit Loss From Real Estate Operations ProfitLossFromRealEstateOperations	2669000
	us-gaap	Profit Loss From Real Estate Operations ProfitLossFromRealEstateOperations	5916000
	us-gaap	Profit Loss From Real Estate Operations ProfitLossFromRealEstateOperations	5559000
CY2021Q4	us-gaap	Sales Type And Direct Financing Leases Lease Receivable SalesTypeAndDirectFinancingLeasesLeaseReceivable	10378000
CY2020Q4	us-gaap	Sales Type And Direct Financing Leases Lease Receivable SalesTypeAndDirectFinancingLeasesLeaseReceivable	11045000
	ffntf	Lease Receivables Interest During Period LeaseReceivablesInterestDuringPeriod	1368000
CY2021	ffntf	Lease Receivables Interest During Period LeaseReceivablesInterestDuringPeriod	2783000
	ffntf	Lease Receivables Lease Payment Received During Period LeaseReceivablesLeasePaymentReceivedDuringPeriod	1800000
CY2021	ffntf	Lease Receivables Lease Payment Received During Period LeaseReceivablesLeasePaymentReceivedDuringPeriod	3450000
CY2022Q2	us-gaap	Sales Type And Direct Financing Leases Lease Receivable SalesTypeAndDirectFinancingLeasesLeaseReceivable	9946000
CY2021Q4	us-gaap	Sales Type And Direct Financing Leases Lease Receivable SalesTypeAndDirectFinancingLeasesLeaseReceivable	10378000
CY2022Q2	us-gaap	Lease Incentive Receivable Current LeaseIncentiveReceivableCurrent	3405000
CY2021Q4	us-gaap	Lease Incentive Receivable Current LeaseIncentiveReceivableCurrent	3630000
CY2022Q2	us-gaap	Lease Incentive Receivable Noncurrent LeaseIncentiveReceivableNoncurrent	6541000
CY2021Q4	us-gaap	Lease Incentive Receivable Noncurrent LeaseIncentiveReceivableNoncurrent	6748000
CY2022Q2	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Remainder Of Fiscal Year SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear	1830000
CY2022Q2	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Next Twelve Months SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths	1575000
CY2022Q2	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Two Years SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears
CY2022Q2	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Three Years SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears
CY2022Q2	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Four Years SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears
CY2022Q2	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Thereafter SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThereafter
CY2022Q2	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived	3405000
CY2022Q2	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Undiscounted Excess Amount SalesTypeAndDirectFinancingLeasesLeaseReceivableUndiscountedExcessAmount	431000
CY2022Q2	ffntf	Sales Type And Direct Financing Leases Present Value Of Minimum Lease Payments SalesTypeAndDirectFinancingLeasesPresentValueOfMinimumLeasePayments	2974000
CY2022Q2	us-gaap	Residual Value Of Leased Asset ResidualValueOfLeasedAsset	6972000
CY2022Q2	us-gaap	Sales Type And Direct Financing Leases Lease Receivable SalesTypeAndDirectFinancingLeasesLeaseReceivable	9946000
CY2022Q2	us-gaap	Lease Incentive Receivable Current LeaseIncentiveReceivableCurrent	3405000
CY2022Q2	us-gaap	Lease Incentive Receivable Noncurrent LeaseIncentiveReceivableNoncurrent	6541000
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	67015000
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	15306000
CY2021	us-gaap	Repayments Of Debt RepaymentsOfDebt	5750000
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	70813000
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	13383000
	us-gaap	Repayments Of Debt RepaymentsOfDebt	2656000
	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	2784000
	us-gaap	Interest Expense Debt InterestExpenseDebt	4178000
CY2022Q2	us-gaap	Long Term Debt LongTermDebt	82934000
CY2022Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	8235000
CY2022Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	74699000
CY2021Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	1490000
CY2022Q2	us-gaap	Other Notes Payable OtherNotesPayable	18363000
CY2022Q2	ffntf	Notes Payable And Convertible Notes NotesPayableAndConvertibleNotes	18363000
CY2021Q4	ffntf	Notes Payable And Convertible Notes NotesPayableAndConvertibleNotes	7906000
CY2021Q4	us-gaap	Debt Instrument Maturity Date Range End1 DebtInstrumentMaturityDateRangeEnd1	2022-12-18
CY2022Q2	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.10
CY2022Q2	us-gaap	Debt Instrument Maturity Date Range End1 DebtInstrumentMaturityDateRangeEnd1	2022-09-01
CY2022Q3	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.20
CY2022Q2	ffntf	Long Term Debt Before Discount Maturities Repayments Of Principal In Remainder Of Fiscal Year LongTermDebtBeforeDiscountMaturitiesRepaymentsOfPrincipalInRemainderOfFiscalYear	8235000
CY2022Q2	ffntf	Long Term Debt Before Discount Maturities Repayments Of Principal In Next Twelve Months LongTermDebtBeforeDiscountMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	0
CY2022Q2	ffntf	Long Term Debt Before Discount Maturities Repayments Of Principal In Year Two LongTermDebtBeforeDiscountMaturitiesRepaymentsOfPrincipalInYearTwo	64326000
CY2022Q2	ffntf	Long Term Debt Before Discount Maturities Repayments Of Principal In Year Three LongTermDebtBeforeDiscountMaturitiesRepaymentsOfPrincipalInYearThree	0
CY2022Q2	ffntf	Long Term Debt Before Discount Maturities Repayments Of Principal In Year Four LongTermDebtBeforeDiscountMaturitiesRepaymentsOfPrincipalInYearFour	12874000
CY2022Q2	ffntf	Long Term Debt Before Discount Maturities Repayments Of Principal In After Year Four LongTermDebtBeforeDiscountMaturitiesRepaymentsOfPrincipalInAfterYearFour	0
CY2022Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	85435000
CY2022Q2	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	2501000
CY2022Q2	us-gaap	Long Term Debt LongTermDebt	82934000
CY2022Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	8235000
CY2022Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	74699000
CY2022Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	16000000000
CY2022Q2	us-gaap	Lessee Finance Lease Term Of Contract1 LesseeFinanceLeaseTermOfContract1	P20Y
	us-gaap	Lessee Finance Lease Option To Extend LesseeFinanceLeaseOptionToExtend	two options to extend the term for five years each.
CY2022Q2	us-gaap	Lessee Finance Lease Renewal Term1 LesseeFinanceLeaseRenewalTerm1	P5Y
	us-gaap	Payments To Acquire Lease Receivables PaymentsToAcquireLeaseReceivables	140000
	us-gaap	Lessee Finance Lease Variable Lease Payment Terms And Conditions LesseeFinanceLeaseVariableLeasePaymentTermsAndConditions	3% annual increases over the life of the agreement
CY2022Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	16000000
	ffntf	Interest Expense Net InterestExpenseNet	700000
CY2020Q4	us-gaap	Shares Outstanding SharesOutstanding	538851252
CY2021	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	55330352
CY2021Q4	us-gaap	Shares Outstanding SharesOutstanding	594181604
	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	43731290
CY2022Q2	us-gaap	Shares Outstanding SharesOutstanding	637912894
	ffntf	Period After Which The Convertibility Of Shares From One Class To Another Become Exercisable PeriodAfterWhichTheConvertibilityOfSharesFromOneClassToAnotherBecomeExercisable	P3Y
CY2022Q2	us-gaap	Shares Outstanding SharesOutstanding	637912894
CY2022Q2	us-gaap	Shares Outstanding SharesOutstanding	637912894
	ffntf	Gains Losses On Change In Fair Value Of Derivatives GainsLossesOnChangeInFairValueOfDerivatives	3074000
	ffntf	Gains Losses On Change In Fair Value Of Derivatives GainsLossesOnChangeInFairValueOfDerivatives	3074000
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	26192237
CY2021Q4	ffntf	Weighted Average Price Per Share Class Of Warrants Or Rights Outstanding WeightedAveragePricePerShareClassOfWarrantsOrRightsOutstanding	0.75
	ffntf	Class Of Warrants Or Rights Issued During Period ClassOfWarrantsOrRightsIssuedDuringPeriod	2999975
	ffntf	Weighted Average Price Per Share Class Of Warrants Or Rights Issued WeightedAveragePricePerShareClassOfWarrantsOrRightsIssued	1
	ffntf	Class Of Warrants Or Rights Exercised During Period ClassOfWarrantsOrRightsExercisedDuringPeriod	88659
	ffntf	Weighted Average Price Per Share Class Of Warrants Or Rights Exercised WeightedAveragePricePerShareClassOfWarrantsOrRightsExercised	0.56
CY2022Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	29103553
CY2022Q2	ffntf	Weighted Average Price Per Share Class Of Warrants Or Rights Outstanding WeightedAveragePricePerShareClassOfWarrantsOrRightsOutstanding	0.75
CY2022Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	29103553
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	60057752
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	49958670
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y8M19D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	50427065
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.84
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y8M19D
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	7900000
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.62
CY2021	ffntf	Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2737326
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.04
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	1306987
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0.43
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	54282752
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.94
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y11M19D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	6435000
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.83
	ffntf	Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedOutstandingWeightedAverageRemainingContractualTerm2	P5Y
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	51975
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.8
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	608025
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	1.62
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	60057752
CY2022Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	428000
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.92
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y8M19D
CY2022Q2	ffntf	Contingent Consideration Payment ContingentConsiderationPayment	1373000
CY2022Q2	ffntf	Contingent Consideration Payment ContingentConsiderationPayment	412000
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	2393000
CY2022Q2	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	600000
CY2022Q1	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	19000000
CY2022Q1	ffntf	Loss Contingency Benefit Value LossContingencyBenefitValue	129000000
CY2022Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	428000
CY2022Q2	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	428000
CY2021Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	3502000
CY2021Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	3502000
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	3502000
CY2020Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	5807000
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-3074000
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	2843000
	ffntf	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease Upon Exercise Of Warrants FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecreaseUponExerciseOfWarrants	0
	ffntf	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease Upon Exercise Of Warrants FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecreaseUponExerciseOfWarrants	-1427000
	us-gaap	Concentration Risk Credit Risk Financial Instrument Maximum Exposure ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure	15823000
CY2021	us-gaap	Concentration Risk Credit Risk Financial Instrument Maximum Exposure ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure	12722000
CY2021Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	7223000
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet	0
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet	0
CY2022Q2	ffntf	Fair Value Equity Level2 To Level1 Transfers Amounts FairValueEquityLevel2ToLevel1TransfersAmounts	0
CY2021Q4	ffntf	Fair Value Equity Level2 To Level1 Transfers Amounts FairValueEquityLevel2ToLevel1TransfersAmounts	0
CY2022Q2	ffntf	Fair Value Equity Level1 To Level2 Transfers Amounts FairValueEquityLevel1ToLevel2TransfersAmounts	0
CY2021Q4	ffntf	Fair Value Equity Level1 To Level2 Transfers Amounts FairValueEquityLevel1ToLevel2TransfersAmounts	0
CY2022Q2	ffntf	Fair Value Assets Level2 To Level1 Transfers Amounts FairValueAssetsLevel2ToLevel1TransfersAmounts	0
CY2021Q4	ffntf	Fair Value Assets Level2 To Level1 Transfers Amounts FairValueAssetsLevel2ToLevel1TransfersAmounts	0
CY2022Q2	ffntf	Fair Value Liabilities Level2 To Level1 Transfers Amounts FairValueLiabilitiesLevel2ToLevel1TransfersAmounts	0
CY2021Q4	ffntf	Fair Value Liabilities Level2 To Level1 Transfers Amounts FairValueLiabilitiesLevel2ToLevel1TransfersAmounts	0
CY2022Q2	ffntf	Fair Value Liabilities Level1 To Level2 Transfers Amounts FairValueLiabilitiesLevel1ToLevel2TransfersAmounts	0
CY2021Q4	ffntf	Fair Value Liabilities Level1 To Level2 Transfers Amounts FairValueLiabilitiesLevel1ToLevel2TransfersAmounts	0
CY2022Q2	ffntf	Fair Value Assets Level1 To Level2 Transfers Amounts FairValueAssetsLevel1ToLevel2TransfersAmounts	0
CY2021Q4	ffntf	Fair Value Assets Level1 To Level2 Transfers Amounts FairValueAssetsLevel1ToLevel2TransfersAmounts	0
CY2021Q4	ffntf	Excess Cash Held With Federally Insured Limits ExcessCashHeldWithFederallyInsuredLimits	10866000
CY2022Q2	ffntf	Cash Held With Bank CashHeldWithBank	9000
CY2022Q2	us-gaap	Contractual Obligation Due In Next Twelve Months ContractualObligationDueInNextTwelveMonths	27657000
CY2022Q2	us-gaap	Contractual Obligation Due In Second And Third Year ContractualObligationDueInSecondAndThirdYear	91899000
CY2022Q2	us-gaap	Contractual Obligation Due In Fourth And Fifth Year ContractualObligationDueInFourthAndFifthYear
CY2022Q2	us-gaap	Contractual Obligation ContractualObligation	119556000
CY2022Q2	us-gaap	Due From Banks DueFromBanks	9000
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2
CY2022Q2	us-gaap	Revenues Revenues	28439000
CY2021Q2	us-gaap	Revenues Revenues	27121000
	us-gaap	Revenues Revenues	54487000
	us-gaap	Revenues Revenues	50091000
CY2022Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1123000
CY2021Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	861000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1970000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1635000
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-6551000
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-6223000
	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	-70000
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	4939000
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	65000
	us-gaap	Net Income Loss NetIncomeLoss	-17312000
CY2022Q2	us-gaap	Assets Assets	320457000
CY2021Q4	us-gaap	Assets Assets	255539000
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	2766000
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	815000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5302000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4563000
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	318000
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-50000
	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	222000
	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	5683000
	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	5163000
	ffntf	Increase Decrease In Equity Attributable IncreaseDecreaseInEquityAttributable	2458000
	ffntf	Increase Decrease In Equity Attributable IncreaseDecreaseInEquityAttributable	-170000
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	3122000
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	17719000
	ffntf	Noncash Activity Change In Right Of Use Assets And Lease Liabilities NoncashActivityChangeInRightOfUseAssetsAndLeaseLiabilities	8000
	ffntf	Noncash Activity Change In Right Of Use Assets And Lease Liabilities NoncashActivityChangeInRightOfUseAssetsAndLeaseLiabilities	153000
	ffntf	Issuance Of Equity To Pay Contingent Consideration IssuanceOfEquityToPayContingentConsideration	0
	ffntf	Issuance Of Equity To Pay Contingent Consideration IssuanceOfEquityToPayContingentConsideration	883000
	ffntf	Issuance Of Debt To Pay Contingent Consideration IssuanceOfDebtToPayContingentConsideration	0
	ffntf	Issuance Of Debt To Pay Contingent Consideration IssuanceOfDebtToPayContingentConsideration	485000
	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	0
	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	1427000
	us-gaap	Noncash Or Part Noncash Acquisition Investments Acquired1 NoncashOrPartNoncashAcquisitionInvestmentsAcquired1	18200000
	us-gaap	Noncash Or Part Noncash Acquisition Investments Acquired1 NoncashOrPartNoncashAcquisitionInvestmentsAcquired1	0
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	15238000
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	0
	us-gaap	Noncash Or Part Noncash Acquisition Payables Assumed1 NoncashOrPartNoncashAcquisitionPayablesAssumed1	2000000
	us-gaap	Noncash Or Part Noncash Acquisition Payables Assumed1 NoncashOrPartNoncashAcquisitionPayablesAssumed1	0
	us-gaap	Noncash Or Part Noncash Acquisition Inventory Acquired1 NoncashOrPartNoncashAcquisitionInventoryAcquired1	213000
	us-gaap	Noncash Or Part Noncash Acquisition Inventory Acquired1 NoncashOrPartNoncashAcquisitionInventoryAcquired1	0
	ffntf	Issuance Of Debt To Acquire Property And Equipment IssuanceOfDebtToAcquirePropertyAndEquipment	14000
	ffntf	Issuance Of Debt To Acquire Property And Equipment IssuanceOfDebtToAcquirePropertyAndEquipment	445000
	ffntf	Inventory Acquired Through Issuance Of Note Payable Noncash Transaction InventoryAcquiredThroughIssuanceOfNotePayableNoncashTransaction	163000
	ffntf	Inventory Acquired Through Issuance Of Note Payable Noncash Transaction InventoryAcquiredThroughIssuanceOfNotePayableNoncashTransaction	0
	ffntf	Cancellation Of Rou Asset And Lease Liability CancellationOfRouAssetAndLeaseLiability	2020000
	ffntf	Cancellation Of Rou Asset And Lease Liability CancellationOfRouAssetAndLeaseLiability	0
	ffntf	Note Payable Issued To Satisfy Accrued Expenses NotePayableIssuedToSatisfyAccruedExpenses	961000
	ffntf	Note Payable Issued To Satisfy Accrued Expenses NotePayableIssuedToSatisfyAccruedExpenses	0
	us-gaap	Interest Paid Net InterestPaidNet	3174000
	us-gaap	Interest Paid Net InterestPaidNet	1662000
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2100000
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	224000
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3504000
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2867000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5960000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11298000
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3042000
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3351000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6480000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6004000

Files In Submission

Name	View Source	Status
0001193125-22-221330-index-headers.html	Edgar Link	pending
0001193125-22-221330-index.html	Edgar Link	pending
0001193125-22-221330.txt	Edgar Link	pending
0001193125-22-221330-xbrl.zip	Edgar Link	pending
d345256d10q.htm	Edgar Link	pending
d345256dex311.htm	Edgar Link	pending
d345256dex312.htm	Edgar Link	pending
d345256dex321.htm	Edgar Link	pending
ffntf-20220630.xsd	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
ffntf-20220630_cal.xml	Edgar Link	unprocessable
ffntf-20220630_def.xml	Edgar Link	unprocessable
ffntf-20220630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
d345256d10q_htm.xml	Edgar Link	completed
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ffntf-20220630_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FFNTF
4Front Ventures Corp. Stock $ffntf

2022 Q3 Form 10-Q Financial Statement

#000119312522221330 Filed on August 15, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FFNTF 4Front Ventures Corp. Stock $ffntf

2022 Q3 Form 10-Q Financial Statement

#000119312522221330 Filed on August 15, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FFNTF
4Front Ventures Corp. Stock $ffntf